<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">CPC </span>
   <span class="font29">influenza </span>
   <span class="font17">virus </span>
   <span class="font17">PMID: </span>
   <span class="font15">Influenza </span>
   <span class="font15">viral </span>
   <span class="font14">activity </span>
   <span class="font13">{border-style </span>
   <span class="font13">clinical </span>
   <span class="font13">px;} </span>
   <span class="font13">resistance </span>
   <span class="font13">viruses </span>
   <span class="font13">μg/mL </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">Figure </span>
   <span class="font13">concentrations </span>
   <span class="font13">mice </span>
   <span class="font12">compared </span>
   <span class="font12">exposure </span>
   <span class="font12">treated </span>
   <span class="font12">treatment </span>
   <span class="font12">envelope </span>
   <span class="font12">susceptible </span>
   <span class="font12">formulation </span>
   <span class="font12">strains </span>
   <span class="font12">using </span>
   <span class="font12">virucidal </span>
   <span class="font12">Central </span>
   <span class="font12">PMCID: </span>
   <span class="font12">determined </span>
   <span class="font12">performed </span>
   <span class="font12">weight </span>
   <span class="font11">ARMS-I </span>
   <span class="font11">demonstrated </span>
   <span class="font11">efficacy </span>
   <span class="font11">infection </span>
   <span class="font11">minutes </span>
   <span class="font11">resistant </span>
   <span class="font11">survival </span>
   <span class="font11">untreated </span>
   <span class="font11">used </span>
   <span class="font11">ARMS- </span>
   <span class="font11">CPC. </span>
   <span class="font11">body </span>
   <span class="font11">concentration </span>
   <span class="font11">mechanism </span>
   <span class="font11">respiratory </span>
   <span class="font11">therapeutic </span>
   <span class="font11">action </span>
   <span class="font11">assay </span>
   <span class="font11">day </span>
   <span class="font11">development </span>
   <span class="font11">disrupted </span>
   <span class="font11">exposed </span>
   <span class="font11">following </span>
   <span class="font11">increased </span>
   <span class="font11">pathogens </span>
   <span class="font11">protection </span>
   <span class="font11">px; </span>
   <span class="font11">significant </span>
   <span class="font11">strain </span>
   <span class="font11">{font-family </span>
   <span class="font11">μg/mL) </span>
   <span class="font11">However, </span>
   <span class="font11">TEM </span>
   <span class="font11">Viral </span>
   <span class="font11">[], </span>
   <span class="font11">analysis </span>
   <span class="font11">cell </span>
   <span class="font11">chloride </span>
   <span class="font11">described </span>
   <span class="font11">effective </span>
   <span class="font11">evaluated </span>
   <span class="font11">font-size </span>
   <span class="font11">hemagglutination </span>
   <span class="font11">hours </span>
   <span class="font11">mean </span>
   <span class="font11">minutes. </span>
   <span class="font11">nucleoprotein </span>
   <span class="font11">oseltamivir </span>
   <span class="font11">oseltamivir-resistant </span>
   <span class="font11">passages </span>
   <span class="font11">prevention </span>
   <span class="font11">prophylactic </span>
   <span class="font11">rapid </span>
   <span class="font11">shown </span>
   <span class="font11">significantly </span>
   <span class="font11">studies </span>
   <span class="font11">use </span>
   <span class="font11">vitro </span>
   <span class="font11">Cetylpyridinium </span>
   <span class="font11">Infect </span>
   <span class="font11">cells </span>
   <span class="font11">collab: </span>
   <span class="font11">double; </span>
   <span class="font11">effect </span>
   <span class="font11">effectiveness </span>
   <span class="font11">experimental </span>
   <span class="font11">including </span>
   <span class="font11">increasing </span>
   <span class="font11">observed </span>
   <span class="font11">potential </span>
   <span class="font11">reduction </span>
   <span class="font11">similar </span>
   <span class="font11">viruses. </span>
   <span class="font11">vivo </span>
   <span class="font10">(EC </span>
   <span class="font10">ARMS-I-treated </span>
   <span class="font10">CPC, </span>
   <span class="font10">CPC-based </span>
   <span class="font10">Dis. </span>
   <span class="font10">MMWR </span>
   <span class="font10">Zhang </span>
   <span class="font10">ability </span>
   <span class="font10">antimicrobial </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">control </span>
   <span class="font10">days </span>
   <span class="font10">direct </span>
   <span class="font10">disruption </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">followed </span>
   <span class="font10">human </span>
   <span class="font10">increase </span>
   <span class="font10">lipid </span>
   <span class="font10">log </span>
   <span class="font10">morbidity </span>
   <span class="font10">multiple </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">prevent </span>
   <span class="font10">reduced </span>
   <span class="font10">results </span>
   <span class="font10">showed </span>
   <span class="font10">solid; </span>
   <span class="font10">strains. </span>
   <span class="font10">sub-inhibitory </span>
   <span class="font10">tested </span>
   <span class="font10">vivo. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(/) </span>
   <span class="font10">(CC </span>
   <span class="font10">-fold </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Clin </span>
   <span class="font10">Committee </span>
   <span class="font10">Esper </span>
   <span class="font10">Exposure </span>
   <span class="font10">Hemagglutination </span>
   <span class="font10">MDCK </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Prevention </span>
   <span class="font10">Research </span>
   <span class="font10">SD. </span>
   <span class="font10">Table </span>
   <span class="font10">acts </span>
   <span class="font10">animals </span>
   <span class="font10">antiviral </span>
   <span class="font10">applied </span>
   <span class="font10">bold </span>
   <span class="font10">broad </span>
   <span class="font10">challenge </span>
   <span class="font10">chicken </span>
   <span class="font10">conferred </span>
   <span class="font10">consistent </span>
   <span class="font10">continued </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">demonstrating </span>
   <span class="font10">determine </span>
   <span class="font10">difference </span>
   <span class="font10">disease </span>
   <span class="font10">disrupts </span>
   <span class="font10">electron </span>
   <span class="font10">em; </span>
   <span class="font10">ensure </span>
   <span class="font10">exhibited </span>
   <span class="font10">experiments </span>
   <span class="font10">exposure, </span>
   <span class="font10">host </span>
   <span class="font10">hpi </span>
   <span class="font10">infectious </span>
   <span class="font10">influenza-associated </span>
   <span class="font10">influenza. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">mortality </span>
   <span class="font10">non-enveloped </span>
   <span class="font10">number </span>
   <span class="font10">oseltamivir-treated </span>
   <span class="font10">percentage </span>
   <span class="font10">post </span>
   <span class="font10">presence </span>
   <span class="font10">propagated </span>
   <span class="font10">pt;} </span>
   <span class="font10">red </span>
   <span class="font10">release </span>
   <span class="font10">strains, </span>
   <span class="font10">susceptibility </span>
   <span class="font10">time </span>
   <span class="font10">times </span>
   <span class="font10">titer </span>
   <span class="font10">toxicity </span>
   <span class="font10">upper </span>
   <span class="font10">virions </span>
   <span class="font10">μg/mL, </span>
  </p>
 </body>
</html>
